How does the pharmaceutical industry influence prescription? A qualitative study of provider payment incentives and drug remunerations in hospitals in Shanghai

Health Economics, Policy and Law

Volumn 11, Issue 4, 2016, Pages 379-395

  Yang, Wei ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

ARTICLE; CHINA; CLINICAL PRACTICE; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HOSPITAL SERVICE; INAPPROPRIATE PRESCRIBING; MEDICAL CARE; MEDICAL SERVICE; MOTIVATION; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PROFIT; PUBLIC HEALTH PROBLEM; QUALITATIVE RESEARCH; SOCIAL CARE; SOCIAL MARKETING; WORKLOAD; DRUG UTILIZATION; ECONOMICS; HUMAN; PERSONNEL MANAGEMENT; PHARMACOECONOMICS; REIMBURSEMENT; REMUNERATION;

CHINA; DRUG COSTS; DRUG INDUSTRY; DRUG UTILIZATION; ECONOMICS, HOSPITAL; ECONOMICS, PHARMACEUTICAL; HUMANS; INAPPROPRIATE PRESCRIBING; MOTIVATION; PHYSICIAN INCENTIVE PLANS; QUALITATIVE RESEARCH; REIMBURSEMENT, INCENTIVE; REMUNERATION;

EID: 84959209474     PISSN: 17441331     EISSN: 1744134X     Source Type: Journal    
DOI: 10.1017/S1744133116000086     Document Type: Article

References (28)

1. Babiarz, K. S., G. Miller, H. Yi, L. Zhang and S. Rozelle (2010), 'New evidence on the impact of China's new rural cooperative medical scheme and its implications for rural primary healthcare: multivariate difference-in-difference analysis', British Medical Journal, 341: 1-9.
2. Babiarz, K. S., G. Miller, H. Yi, L. Zhang and S. Rozelle (2012), 'China's new cooperative medical scheme improved finances of township health centers but not the number of patients served', Health Affairs, 31(5): 1065-1074.
3. Blomqvist, A. and J. Qian (2008), 'Health system reform in China: an assessment of recent trends', Singapore Economic Review, 53(1): 5-26.
4. Eggleston, K., L. Ling, Q. Y. Meng, M. Lindelowand A.Wagstaff (2008), 'Health service delivery in China: A literature review', Health Economics, 17(2): 149-165. doi:10.1002/hec.1306.
5. He, J. A. and W. Yang (2015), 'Clinical pathways in China - an evaluation', International Journal of Health Care Quality Assurance, 28(4): 394-411.
6. Liu, H., S. Gao and J. A. Rizzo (2011), 'The expansion of public health insurance and the demand for private health insurance in rural China', China Economic Review, 22(1): 28-41.
7. Liu, X. Y., R. Thomson, Y. L. Gong, F. Z. Zhao, S. B. Squire, R. Tolhurst, X. P. Zhao, F. Yan and S. L. Tang (2007), 'How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives', Tropical Medicine & International Health, 12(12): 1464-1471.
8. Meng, Q. Y., G. Cheng, L. Silver, X. J. Sun, C. Rehnberg and G. Tomson (2005), 'The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals', Health Policy and Planning, 20(3): 185-196.
9. Ng, Y. C. (2011), 'The productive efficiency of Chinese hospitals', China Economic Review, 22(3): 428-439.
10. Peiming, Y., S. Lili and Y. Shumei (2010), 'Centralised drug bidding mechanism: issues and challenges (in Chinese)', China Journal of Pharmaceutical Economics, 4(1): 51.
11. Ramesh, M., Xun Wu and A. J. He (2014), 'Health governance and health reforms in China', Health Policy and Planning, 29(6): 663-672.
12. Reynolds, L. and M. McKee (2009), 'Factors influencing antibiotic prescribing in China: an exploratory analysis', Health Policy, 90(1): 32-36.
13. The State Council of P.R. China (2015a), State Council's Opinion on Improving Centralised Drug Purchasing System in Public Hospitals (in Chinese), Beijing: The State Council of P.R. China.
14. The State Council of P.R. China (2015b), State Council's Opinion on Medical Technology Assessment and Appraisals on Pharmaceutical Products and Medical Devices (in Chinese), Beijing: The State Council of P.R. China.
15. Wagstaff, A. and M. Lindelow (2008), 'Can insurance increase financial risk? The curious case of health insurance in China', Journal of Health Economics, 27(4): 990-1005.
16. Wagstaff, A. and S. Yu, World Bank. Development Research Group. Public Services (2005), Do Health Sector Reforms have their Intended Impacts?: The World Bank's Health VIII Project in Gansu Province, China. Policy Research Working Papers. Washington, DC: World Bank, Development Research Group, Public Services Team.
17. Wagstaff, A., W. Yip, M. Lindelow and W. C. Hsiao (2009), 'China's health system and its reform: a review of recent studies', Health Economics, 18: S7-S23.
18. Wang, Z. and Z. Cai (2015), 'The impacts of zero mark-up policy on hospital financing (in Chinese)', Health Economics Research, 5(337): 56.
19. Wang, Z.-h., Z. Mao and W. Du (2015), 'Policy effectiveness analysis of pilot reform in centralized drug purchasing: case study of Sanming City, Fujian province (in Chinese)', Chinese Journal of Health Policy, 1(8): 21.
20. Xu, H. (2010), 'Econometric analysis of influential factors on the policy of zero price based on logit model: a case study of Hexi, Tanggu District (in Chinese)', Chinese Rural Health Service Administration, 30(5): 336.
21. Yang, W. (2014), 'Catastrophic outpatient health payments and health payment-induced poverty under China's new rural cooperative medical scheme.' Applied Economic Perspectives and Policy, doi:10.1093/aepp/ppu017.
22. Yang, W. and X. Wu (2014), 'Paying for outpatient care in rural China: cost escalation under China's new co-operative medical scheme', Health Policy and Planning, doi:10.1093/heapol/czt111.
23. Yi, H., G. Miller, L. Zhang, S. Li and S. Rozelle (2015), 'Intended and unintended consequences of China's zero markup drug policy', Health Affairs, 34(8): 1391-1398.
24. Yip, W. and K. Eggleston (2004), 'Addressing government and market failures with payment incentives: hospital reimbursement reform in Hainan, China', Social Science & Medicine, 58(2): 267-277.
25. Yip, W. and W. C. Hsiao (2008), 'Market watch - the Chinese health system at a crossroads', Health Affairs, 27(2): 460-468.
26. Yip, W. and W. Hsiao (2009), 'China's health care reform: a tentative assessment', China Economic Review, 20(4): 613-619.
27. Yip, W. C. M., W. C. Hsiao, W. Chen, S. L. Hu, J. Ma and A. Maynard (2012), 'Early appraisal of China's huge and complex health-care reforms', Lancet, 379(9818): 833-842.
28. Zhang, J., G. Liu, Y. Chu and W. Li (2014), 'Analysis of medical expense changes before or after implementing drug's zero profit policy in township health center in Guizhou (in Chinese)', Chinese Primary Health Care, 28(4): 6.